Toward total implantability using free-range resonant electrical energy delivery system: achieving untethered ventricular assist device operation over large distances.

[1]  Pramod Bonde,et al.  4 National Trends in Readmission(REA) Rates Following Left Ventricular Assist Device (LVAD) Therapy , 2011 .

[2]  Ashish S Shah,et al.  Infectious complications after pulsatile-flow and continuous-flow left ventricular assist device implantation. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[3]  V. Thourani.  Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: Incidence, risk factors, and effect on outcomes , 2011 .

[4]  Nader Moazami,et al.  Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era. , 2010, The Annals of thoracic surgery.

[5]  Linda Wellington,et al.  Effect of body mass index and device type on infection in left ventricular assist device support beyond 30 days. , 2010, Interactive cardiovascular and thoracic surgery.

[6]  Martin Cadeiras,et al.  Device Related Infections: Are We Making Progress? , 2010, Journal of cardiac surgery.

[7]  Robert L Kormos,et al.  Infection after implantation of pulsatile mechanical circulatory support devices. , 2010, The Journal of thoracic and cardiovascular surgery.

[8]  Ashish S Shah,et al.  Quality of life and functional status in patients surviving 12 months after left ventricular assist device implantation. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[9]  Marc A. Simon,et al.  261: The Ventricular Assist Device (VAD) Driveline: What Is the Price of Living with This Technology? , 2010 .

[10]  Walter R Wilson,et al.  Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. , 2010, Circulation.

[11]  Deborah Budge,et al.  Obesity and Left Ventricular Assist Device Driveline Exit Site Infection , 2010, ASAIO journal.

[12]  S. Russell,et al.  Advanced heart failure treated with continuous-flow left ventricular assist device. , 2009, The New England journal of medicine.

[13]  Marc A Simon,et al.  Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation. , 2009, The Annals of thoracic surgery.

[14]  Nader Moazami,et al.  Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. , 2009, Journal of the American College of Cardiology.

[15]  Robert L Kormos,et al.  Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[16]  S. Kurtz,et al.  Infection burden for hip and knee arthroplasty in the United States. , 2008, The Journal of arthroplasty.

[17]  O H Frazier,et al.  Use of a continuous-flow device in patients awaiting heart transplantation. , 2007, The New England journal of medicine.

[18]  Nader Moazami,et al.  Late-onset driveline infections: the Achilles' heel of prolonged left ventricular assist device support. , 2007, The Annals of thoracic surgery.

[19]  Christopher Bowles,et al.  Midterm experience with the Jarvik 2000 axial flow left ventricular assist device. , 2007, The Journal of thoracic and cardiovascular surgery.

[20]  S. Furukawa,et al.  Infections associated with ventricular assist devices: epidemiology and effect on prognosis after transplantation , 2005, Transplant infectious disease : an official journal of the Transplantation Society.

[21]  F. Lowy,et al.  Ventricular assist device-related infections. , 2006, The Lancet. Infectious diseases.

[22]  G. Couper,et al.  Infection in permanent circulatory support: experience from the REMATCH trial. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[23]  Walter R Wilson,et al.  Nonvalvular Cardiovascular Device–Related Infections , 2003, Circulation.

[24]  Michiel Morshuis,et al.  Preliminary experience with the LionHeart left ventricular assist device in patients with end-stage heart failure. , 2003, The Annals of thoracic surgery.

[25]  F Beyersdorf,et al.  The Jarvik 2000 is associated with less infections than the HeartMate left ventricular assist device. , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[26]  R. Kormos,et al.  Mechanical Circulatory Support device database of the International Society for Heart and Lung Transplantation: first annual report--2003. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[27]  B. Griffith,et al.  Human factors issues in ventricular assist device recipients and their family caregivers. , 2000, ASAIO journal.

[28]  M. Hravnak,et al.  Management of chronic left ventricular assist device percutaneous lead insertion sites. , 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[29]  S. Rogers,et al.  Prevention of infective endocarditis' , 1988, British Dental Journal.